Notice regarding Tirzepatide and the end of the shortage Hey there everyone, Yesterday evening it was brought to our attention that the FDA has officially ended the shortage for Eli Lilly’s branded variants of Tirzepatide (Mounjaro®, Zep Bound®). This was expected, as Eli Lilly has announced multiple times over the past few months that they […]
TRYM Health™ is a patient management and subscription platform that works with independent compounding pharmacies who provide services using TRYM’s Platform. TRYM Health does not directly provide medical or pharmacy services.
Operating 9 AM – 5 PM on weekdays. The information provided on this website is for informational purposes and not a substitute for professional medical advice, diagnosis, or treatment
TRYM Health Group
Copyright © 2025 All rights reserved.
